February 2022

NEWS & COLUMNS

6-7 NEWS
AstraZeneca’s Enhertu gets FDA priority review; EMA proposes EU clinical trial reforms

8-9 NEWS
Pfizer and Acuitas Therapeutics deal; FDA places partial clinical hold on three Gilead trials

10-11 CORONAVIRUS NEWS
Pfizer CEO plans Omicron-specific vaccine; FDA restricts certain COVID-19 antibody treatments

12 DARWIN'S MEDICINE
It's not about the technology

13 POLICY AND PUBLIC HEALTH
The US and Canada's decisions regarding COVID-19

14 WHEN SHALL WE MEET AGAIN?
The new rules of engagement in a virtual world

15 PHARMA MARKETERS' BLOG
Team capabilities are evolving in a changing world

FEATURES

16-17 STRIVING FOR GREATER PRICE TRANSPARENCY
The search for a more ethical way to distribute medicines globally

18-19 FAIRER AND FASTER ACCESS TO MEDICINES IN THE NHS
How the COVID-19 pandemic highlighted issues within the healthcare system

20-21 CLINICAL TRIALS FOR THE NEW NORMAL
The key factors needed to adapt to patient-centric clinical trials

24-25 AI: A SMART BET FOR THE PHARMA INDUSTRY
How AI and machine learning is helping
to discover new drugs

28 RESEARCH NEWS
Northumbria University's Parkinson’s research project; UCL's new £60m facility